序号 |
标题 |
次数 |
作者 |
发布时间 |
68896 |
cas:2143958-58-9,Methyltetrazine-CH2NHCO-PEG8-CH2CH2NH2 ,小分子peg |
98 |
kx |
2024-12-27 |
68897 |
DBCO-PEG-Maleimide (PEG1-PEGn),1480516-75-3 ,ADC试剂 |
107 |
hyy |
2024-12-27 |
68898 |
cas:141976-28-3,Methyltetrazine-CH2NHCO-PEG3-CH2CH2NH2 |
77 |
kx |
2024-12-27 |
68899 |
Methyltetrazine-CH2NHCO-PEG9-N3,小分子peg |
113 |
kx |
2024-12-27 |
68900 |
Propyne-PEG3-NH-PEG-NH2 |
81 |
h |
2024-12-27 |
68901 |
四羧基金属酞菁是指具有四个羧基的金属酞菁化合物 |
101 |
WYQ |
2024-12-27 |
68902 |
DBCO-PEG-DBCO (PEG1-PEGn),2182601-68-7,抗体- 药物偶联物 |
68 |
hyy |
2024-12-27 |
68903 |
芳醚树枝状酞菁锌G1-ZnPc(COOH)8和G2-ZnPc(COOH)16 |
74 |
WYQ |
2024-12-27 |
68904 |
Methyltetrazine-CH2NHCO-PEG4-N3,小分子peg |
127 |
kx |
2024-12-27 |
68905 |
DBCO-NH-PEG2-CH2CH2COONHS ester,小分子peg |
104 |
kx |
2024-12-27 |
68906 |
DBCO-Sulfo-Link-biotin,1363444-70-5,ADC试剂 |
106 |
hyy |
2024-12-27 |
68907 |
2,9,16,23-四氨基锌酞菁,四氨基取代的金属酞菁化合物 |
54 |
WYQ |
2024-12-27 |
68908 |
cas:1255942-07-4,DBCO-NH-PEG4-Biotin ,DBCO-PEG4-生物素 |
67 |
kx |
2024-12-27 |
68909 |
单羧基取代的不对称酞菁锌配合物 |
88 |
WYQ |
2024-12-27 |
68910 |
二-(3,5-二(1',3'-甲基吡啶基丙烷氧基)苯甲氧基)轴向取代硅酞菁(IV)(N1SiPc) |
91 |
WYQ |
2024-12-27 |
68911 |
DBCO-PEG-Biotin (PEG1-PEGn),1255942-07-4,抗体- 药物偶联物 |
85 |
hyy |
2024-12-27 |
68912 |
2228857-34-7,DBCO-NH-PEG1-CH2CH2COONHS Ester,氮杂二苯并环辛炔单聚乙二醇琥珀酰亚胺酯 |
67 |
kx |
2024-12-27 |
68913 |
mPEG-Pyridyl disulfide |
65 |
h |
2024-12-27 |
68914 |
HS-(CH2)6-O-PEG8-OCH3 |
68 |
h |
2024-12-27 |
68915 |
DBCO-NHCO-PEG4-NH-Boc,1255942-12-1,ADC试剂 |
60 |
hyy |
2024-12-27 |
68916 |
Maleimide-(CH2)10-COONHS cas:87981-04-2 |
108 |
h |
2024-12-27 |
68917 |
二-(3-甲氧羰基-5-(4-苯酰基苯甲氧基)苯氧基)轴向取代硅(Ⅳ)酞菁(SiPc-E-BP) |
79 |
WYQ |
2024-12-27 |
68918 |
他莫昔芬-酞菁锌轭合物,分子靶向抗癌光敏剂 |
176 |
WYQ |
2024-12-27 |
68919 |
含聚乙二醇链的酞菁化合物 |
77 |
WYQ |
2024-12-27 |
68920 |
氟代烷基硅酞菁-芘环糊精-单壁碳纳米管复合体系 |
66 |
WYQ |
2024-12-27 |
68921 |
两亲性光敏剂五聚赖氨酸酞菁锌 |
90 |
WYQ |
2024-12-27 |
68922 |
Maleimide-(CH2)2-COOH cas:7423-55-4 |
55 |
h |
2024-12-27 |
68923 |
ZGO-SHPP-ZnPc 基于酞菁锌的纳米光敏剂 |
82 |
WYQ |
2024-12-27 |
68924 |
(+)-Biotin-PEG6-CH2CH2NH2 |
88 |
h |
2024-12-27 |
68925 |
四-(4-(二苯基氨基)-1-联苯基)巯基锌(II)酞菁(ZnPc-TPA) |
117 |
WYQ |
2024-12-27 |
68926 |
(+)-Biotin-PEG3-CH2CH2N3 cas:875770-34-6 |
66 |
h |
2024-12-27 |
68927 |
(+)-Biotin-CH2CH2NH2 |
56 |
h |
2024-12-27 |
68928 |
(+)-Biotin-LC-Hydrazide cas:109276-34-8 |
125 |
h |
2024-12-27 |
68929 |
DBCO-Sulfo-PEG4-amine,2055198-05-3 ,ADC试剂 |
70 |
hyy |
2024-12-27 |
68930 |
mPEG10-CH2COOH cas:908258-58-2 |
149 |
h |
2024-12-27 |
68931 |
SPDP-PEG10-乙酸乙酯,SPDP-PEG10-CH2CH2COOH |
76 |
wyh |
2024-12-27 |
68932 |
SPDP-PEG10-乙酸乙酯,SPDP-PEG10-CH2CH2COOH |
67 |
wyh |
2024-12-27 |
68933 |
N3-PEG12-CH2CH2COOtBu,叠氮十二聚乙二醇丙酸叔丁酯 |
105 |
wyh |
2024-12-27 |
68934 |
DBCO-NHCO-PEG-amine (PEG1-PEGn),1255942-08-5,抗体- 药物偶联物 |
66 |
hyy |
2024-12-27 |
68935 |
二-(4-(苯酚基)-1,1,1,3,3,3-六氟代丙烷基-4苯氧基)轴向取代硅(IV)酞菁(FBPA-SiPc) |
71 |
WYQ |
2024-12-27 |
68936 |
CBZ-NH-PEG1-CH2CH2COOH,苄氧羰基聚乙二醇乙酸 |
150 |
wyh |
2024-12-27 |
68937 |
Propargyl-PEG4-acid cas:1415800-32-6 炔丙基四聚乙二醇-酸 |
71 |
zyl |
2024-12-27 |
68938 |
酞菁光敏剂(ZnPc-OH),含有羟基(-OH)官能团的酞菁锌(ZnPc)化合物 |
129 |
WYQ |
2024-12-27 |
68939 |
mPEG4-CH2COOH cas:16024-66-1 |
74 |
h |
2024-12-27 |
68940 |
H2N-PEG8-CH2COOtBu的结构特点 |
126 |
wyh |
2024-12-27 |